Investigators at Johns Hopkins University say they may have found a new way to more accurately predict prostate cancer patients’ prognoses than the current method, which uses disease stage, Gleason score, and PSA levels.
Continue Reading
John Schieszer reports in today’s Medical Minute that a new technique called TELI-FISH (telomere-specific fluorescent in situ hybridization) may turn out to be an important new tool for urologists.
Enjoying our content?
Thanks for visiting Renal & Urology News. We hope you’re enjoying the latest clinical news, full-length features, case studies, and more.
You’ve viewed {{metering-count}} of {{metering-total}} articles this month. If you wish to read unlimited content, please log in or register below. Registration is free.
{{login-button}} {{register-button}}
Log in to continue reading this article.
Don’t miss out on today’s top content on Renal & Urology News. Register for free and gain unlimited access to:
- Clinical News, with personalized daily picks for you
- Case Studies
- Conference Coverage
- Full-Length Features
- Drug Monographs
- And More
{{login-button}} {{register-button}}
Want to read more?
Please login or register first to view this content.